ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
3D Systems announced FDA approval for a groundbreaking 3D-printed bioabsorbable medical device, COAPTIUM® CONNECT with TISSIUM Light, designed for the repair of peripheral nerve damage. This ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Imperative Care, Inc. announced the enrollment of the first patient in the prospective observational CLEAR-IT clinical study ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system enabled ...
– Provides interventionalists with optimal product choices for more complex radial-to-peripheral procedures – SOMERSET, N.J., Dec. 3, 2024 /PRNewswire/ -- Terumo Interventional Systems (TIS), a ...
Others, however, believed that the peripheral nervous system (nerves that connect the body's extremities to the brain) played a larger role, as nerves in the moving limbs produced feedback signals ...
Imperative Care has enrolled the first patient in its CLEAR-IT Study, which aims to assess the Symphony and Prodigy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results